| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 74 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 72 |
| 2 | TACROLIMUS OINTMENT 0.1% | 72 |
| 3 | MYCOPHENOLATE MOFETIL | 53 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 53 |
| 5 | CYCLOPHOSPHAMIDE | 37 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 37 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 37 |
| 8 | FLUDARABINE PHOSPHATE | 35 |
| 9 | BUSULFAN | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIMETHAMINE | 5 | 0.0039 |
| 1 | THIOTEPA | 24 | 0.0025 |
| 2 | BUSULFAN | 29 | 0.0018 |
| 3 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 4 | QUIZARTINIB | 1 | 0.0014 |
| 5 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 6 | FLUDARABINE PHOSPHATE | 35 | 0.0009 |
| 7 | ATOVAQUONE | 7 | 0.0008 |
| 8 | POSACONAZOLE | 13 | 0.0008 |
| 9 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 5 | 0.0039 |
| 1 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 2 | Antimalarial [EPC] | 7 | 0.0007 |
| 3 | Antiprotozoal [EPC] | 7 | 0.0007 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 6 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 8 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 9 | Alkylating Drug [EPC] | 49 | 0.0002 |